Saint-Germain Pharma Limited - Accounts to registrar (filleted) - small 17.3

Saint-Germain Pharma Limited - Accounts to registrar (filleted) - small 17.3


IRIS Accounts Production v17.3.1.106 10218474 director 7.6.16 30.6.17 30.6.17 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure102184742016-06-06102184742017-06-30102184742016-06-072017-06-30102184742016-06-0610218474ns15:EnglandWales2016-06-072017-06-3010218474ns14:PoundSterling2016-06-072017-06-3010218474ns10:Director12016-06-072017-06-3010218474ns10:PrivateLimitedCompanyLtd2016-06-072017-06-3010218474ns10:Micro-entities2016-06-072017-06-3010218474ns10:AuditExemptWithAccountantsReport2016-06-072017-06-3010218474ns10:FullAccounts2016-06-072017-06-3010218474ns10:RegisteredOffice2016-06-072017-06-30


REGISTERED NUMBER: 10218474 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE PERIOD 7 JUNE 2016 TO 30 JUNE 2017

FOR

SAINT-GERMAIN PHARMA LIMITED

SAINT-GERMAIN PHARMA LIMITED (BY SHARES) (REGISTERED NUMBER: 10218474)

CONTENTS OF THE FINANCIAL STATEMENTS
for the Period 7 June 2016 to 30 June 2017










Page

Company Information 1

Balance Sheet 2

Chartered Accountants' Report 3

SAINT-GERMAIN PHARMA LIMITED (BY SHARES)

COMPANY INFORMATION
for the Period 7 June 2016 to 30 June 2017







DIRECTOR: A S M Dean





REGISTERED OFFICE: Linden House
Linden Close
Tunbridge Wells
Kent
TN4 8HH





REGISTERED NUMBER: 10218474 (England and Wales)





ACCOUNTANTS: BSR Bespoke Chartered Accountants
Linden House
Linden Close
Tunbridge Wells
Kent
TN4 8HH

SAINT-GERMAIN PHARMA LIMITED (BY SHARES) (REGISTERED NUMBER: 10218474)

BALANCE SHEET
30 June 2017

£   
CURRENT ASSETS 100
NET CURRENT ASSETS 100
TOTAL ASSETS LESS CURRENT
LIABILITIES

100

CAPITAL AND RESERVES 100

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 30 June 2017.

The members have not required the company to obtain an audit of its financial statements for the period ended 30 June 2017 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

The financial statements were approved by the director on 6 March 2018 and were signed by:





A S M Dean - Director


CHARTERED ACCOUNTANTS' REPORT TO THE DIRECTOR
ON THE UNAUDITED FINANCIAL STATEMENTS OF
SAINT-GERMAIN PHARMA LIMITED (BY SHARES)


The following reproduces the text of the report prepared for the director in respect of the company's annual
unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file
a Balance Sheet. Readers are cautioned that the Income Statement is not required to be filed with the Registrar
of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the
financial statements of Saint-Germain Pharma Limited for the period ended 30 June 2017 which comprise the Income
Statement and the Balance Sheet from the company's accounting records and from information and explanations you
have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the director of Saint-Germain Pharma Limited in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Saint-Germain Pharma Limited and state those matters that we have agreed to state to the director of Saint-Germain Pharma Limited in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Saint-Germain Pharma Limited and its director for our work or for this report.

It is your duty to ensure that Saint-Germain Pharma Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Saint-Germain Pharma Limited. You consider that Saint-Germain Pharma Limited is exempt from the statutory audit requirement for the period.

We have not been instructed to carry out an audit or a review of the financial statements of Saint-Germain Pharma Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






BSR Bespoke Chartered Accountants
Linden House
Linden Close
Tunbridge Wells
Kent
TN4 8HH


6 March 2018